Global Anti-Fungal Drugs Market Expected to Register at a CAGR of 3.7%

Global Anti-Fungal Drugs Market

Global Anti-Fungal Drugs Market View:

The Global Anti-fungal Drugs Market is expected to witness a CAGR of approximately 3.7% during the forecast period to reach a value of USD XX Billion by 2023 from its market value of USD XX Billion. Antifungal drugs are used in the treatment of diseases caused by the fungal pathogens in the human body. The fungal agents enter the body through unclean surroundings and sometimes become fatal leading to death. Candidiasis, fungal pneumonia, and mucormycosis are some of the common fungal infections.

Browse details of research report developed on Global Anti-Fungal Drugs Market @

Anti-Fungal Affecting Organs in Body:

Fungal infections commonly affect the areas of the human body like skin, eye, mouth, vagina and others, which can lead diseases like athlete’s foot, fungal meningitis, and ringworm. Antifungal drugs include different kinds of tablets, injections, sprays and creams that can provide relief to the sufferers. Systemic candidiasis is the most common fungal infection that is expected to grow in the forecast period, and azole is the most used antifungal drug in recent times.

The increasing adoption of over the counter drugs for common infections is the primary factor driving the Global Anti-Fungal Drugs Market. Additionally, the growing awareness about health care, the rising health care spending of the people, R&D expenditure by the public and private organizations, unhealthy lifestyles, increasing geriatric population, the advent of technology in the medical care, and the government and corporate investments in the drug discovery are also promoting the worldwide antifungal drugs market. On the contrary, the use of traditional drugs and lack of proper care in the remote areas are restricting the expansion of the market.

Avail Sample Market Brochure of the report for more information, Get a Copy @

Global Anti-Fungal Drugs Market Geographical Analysis:

Based on geography, North America leads the Global Anti-Fungal Drugs Market due to the availability of key players, increasing preference for over the counter drugs, early adoption of technology and sophisticated healthcare infrastructure. Europe is in the second position of the market and increasing with the development of distinct antifungal biomedicines. The Asia Pacific region is expected to register the highest CAGR owing to the growing population and economies of the countries like India and China, increasing awareness about personal hygiene, rise in the per capita income and improved access to healthcare facilities.

Global Anti-Fungal Drugs Market Key Players:

Merck & Co., Inc., Novartis AG, Sanofi-Aventis, Pfizer, Inc., Bayer AG, Enzon Pharmaceuticals, Inc., GlaxoSmithKline plc, Abbott, and Sigma-Aldrich are some of the leading companies in the Global Anti-Fungal Drugs Market.

Inquire Before Buying@

About Us:

Research Cosmos is a provider of standard and customized market research, business intelligence
and consulting services across more than 100 domains in different industries of the world. We host
the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden
opportunities in every leading industry of the world.


Kevin Stewart
Global Sales Manager
Research Cosmos
+1 888 709 8757

Be the first to comment

Leave a Reply